ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft

ClinicalTrials.gov ID: NCT02649946

Public ClinicalTrials.gov record NCT02649946. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 9:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multi-Center, Randomized, Concurrently-Controlled Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in the Treatment of Stenosis in the Venous Outflow of AV Fistula Access Circuits (AVeNEW)

Study identification

NCT ID
NCT02649946
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
C. R. Bard
Industry
Enrollment
280 participants

Conditions and interventions

Interventions

  • Covera Vascular Covered Stent following PTA Device
  • Percutaneous Transluminal Angioplasty (PTA) with Uncoated PTA Balloon Procedure

Device · Procedure

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2016
Primary completion
Jul 31, 2018
Completion
Jan 31, 2021
Last update posted
Dec 20, 2021

2016 – 2021

United States locations

U.S. sites
16
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
Southwest Vascular Center Tempe Arizona 85281
Alliance Research Centers Laguna Hills California 92653
Radiology Imaging Associates Englewood Colorado 80112
Yale University & Yale New Haven Hospital New Haven Connecticut 06520
Nephrology Associates, P.A. Newark Delaware 19713
Jacksonville Center for Clinical Research Jacksonville Florida 32207
First Coast Cardiovascular Institute Jacksonville Florida 32216
Ocala Kidney Group Ocala Florida 34471
Chicago Access Care Chicago Illinois 60521
Indiana University Hospital Indianapolis Indiana 46202
Renal and Transplant Associates of New England, P.C. West Springfield Massachusetts 01089
NC Heart and Vascular Research Raleigh North Carolina 27607
NC Nephrology Raleigh North Carolina 27610
Providence Access Care Providence Rhode Island 02906
Tarrant Vascular Clinic Fort Worth Texas 76104
Clinical Advancement Center, PLLC San Antonio Texas 78215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02649946, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 20, 2021 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02649946 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →